1. Understanding breast cancer heterogeneity through non-genetic heterogeneity

   • Neda Barzgar Barough
   • Fakhrosadat Sajjadian
   • Kobra Velaei

   Review Article 15 March 2021 Pages: 777 - 791

   

2. Immune-related biomarkers in triple-negative breast cancer

   • Juan Zhang
   • Qi Tian
   • Jin Yang

   Review Article Open access 09 April 2021 Pages: 792 - 805

   

3. Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer

   • Xuemin Liu
   • Qingyu Chang
   • Yikun Jiang

   Original Article Open access 21 January 2021 Pages: 806 - 821

   

4. Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 − negative subtype

   • Yuko Tanaka
   • Takashi Ohno
   • Yoshihisa Umekita

   Original Article 22 January 2021 Pages: 822 - 828

   

5. Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway

   • Lei Du
   • Xingguang Tao
   • Xiaowei Shen

   Original Article 26 March 2021 Pages: 829 - 837

   

6. Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer

   • Tomohiro Ochi
   • Hiroko Tsunoda
   • Hideko Yamauchi

   Original Article 09 February 2021 Pages: 838 - 847

   

7. Adenosquamous carcinoma of the breast: a population-based study

   • Cheng Xu
   • Zhangyuan Gu
   • Zhigang Zhuang

   Original Article Open access 12 February 2021 Pages: 848 - 858

   

8. Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells

   • Yingzi Zhang
   • Jiao Tian
   • Shengchun Liu

   Original Article Open access 10 February 2021 Pages: 859 - 873

   

9. Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society

   • Sungmin Park
   • Joon Jeong
   • Soo Youn Bae

   Original Article 14 February 2021 Pages: 874 - 883

   

10. A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin

    • Xiaozhong Teng
    • Tetsu Hayashida
    • Yuko Kitagawa

    Original Article 22 February 2021 Pages: 884 - 895

    

11. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study

    • Kiyo Tanaka
    • Norikazu Masuda
    • Hiroji Iwata

    Original Article Open access 18 February 2021 Pages: 896 - 903

    

12. Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer

    • Hajime Kuroda
    • Tsengelmaa Jamiyan
    • Atsuko Masunaga

    Original Article Open access 25 February 2021 Pages: 904 - 914

    

13. Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases

    • Hiroyuki Minemura
    • Kiyoshi Takagi
    • Takashi Suzuki

    Original Article 12 March 2021 Pages: 915 - 926

    

14. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast

    • Mitsuhiro Tozaki
    • Hidetake Yabuuchi
    • Hiroshi Nakahara

    Original Article 24 February 2021 Pages: 927 - 936

    

15. Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population

    • Azin Nahvijou
    • Hossein Safari
    • Hosein Ameri

    Original Article 05 March 2021 Pages: 937 - 943

16. Correction to: Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population

    • Azin Nahvijou
    • Hossein Safari
    • Hosein Ameri

    Correction 26 March 2021 Pages: 944 - 944

17. Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan

    • Masato Takahashi
    • Kenichi Inoue
    • Junji Tsurutani

    Original Article Open access 07 March 2021 Pages: 945 - 955

    

18. Breast cancer preoperative ¹⁸FDG-PET, overall survival prognostic separation compared with the lymph node ratio

    • Vincent Vinh-Hung
    • Hendrik Everaert
    • Mark De Ridder

    Original Article 10 March 2021 Pages: 956 - 968

    

19. Practical approach to prevent COVID-19 infection at breast cancer screening

    • Mamoru Takada
    • Gaku Tanaka
    • Fumio Imazeki

    Original Article Open access 02 April 2021 Pages: 969 - 976

    

20. Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer

    • Ako Ohara
    • Yasuto Naoi
    • Shinzaburo Noguchi

    Rapid Communication 16 February 2021 Pages: 977 - 982

    

21. Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition

    • Takayoshi Uematsu
    • Kazutaka Nakashima
    • Hiroji Iwata

    Correction Open access 19 May 2021 Pages: 983 - 984

22. Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition

    • Tatsunori Shimoi
    • Shigenori E. Nagai
    • Tatsuya Toyama

    Correction Open access 22 April 2021 Pages: 985 - 986

23. Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient

    • Hiroji Iwata
    • Shigehira Saji
    • Chikako Yamauchi

    Correction Open access 19 May 2021 Pages: 987 - 987

24. Correction to: The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition

    • Chikako Yamauchi
    • Michio Yoshimura
    • Hiroji Iwata

    Correction Open access 19 May 2021 Pages: 988 - 988

25. Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition

    • Masafumi Inokuchi
    • Goro Kutomi
    • Hiroji Iwata

    Correction Open access 19 May 2021 Pages: 989 - 989